Positron

Positron Documents

Documents

100

Ticker

POSC

ISIN

US7373976049

Revenue Net Income P/E P/S EBIT Dividend Directors Dealings Stocks Market capitalization Debt Liabilities Equity AAQS Employees ROE ROA ROCE News Documents

Positron SEC Filings

Type
Report
Date
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben12/30/2025
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben12/16/2025
10-12G10-12G-Formular11/12/2025
15-12G15-12G-Formular5/2/2019
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben8/1/2018
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben5/10/2016
NT 10-KNT 10-K-Formular3/31/2016
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben2/22/2016
10-QQuartalsbericht11/23/2015
NT 10-QNT 10-Q-Formular11/16/2015
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben10/5/2015
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben9/11/2015
10-QQuartalsbericht8/14/2015
10-QQuartalsbericht5/15/2015
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben12/22/2014
10-Q/A10-Q/A-Formular12/15/2014
10-Q/A10-Q/A-Formular12/15/2014
10-Q/A10-Q/A-Formular12/15/2014
DEF 14CDEF 14C-Formular11/18/2014
10-QQuartalsbericht11/14/2014
PRE 14CPRE 14C-Formular11/7/2014
4Insidertransaktion9/12/2014
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben9/8/2014
10-QQuartalsbericht8/14/2014
4Insidertransaktion7/7/2014
10-Q/A10-Q/A-Formular5/16/2014
10-QQuartalsbericht5/15/2014
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben12/27/2013
CORRESPCORRESP-Formular12/17/2013
PRER14CPRER14C-Formular12/13/2013
CORRESPCORRESP-Formular11/27/2013
UPLOADUPLOAD-Formular11/26/2013
CORRESPCORRESP-Formular11/22/2013
PRE 14CPRE 14C-Formular11/19/2013
10-Q/A10-Q/A-Formular11/18/2013
10-QQuartalsbericht11/14/2013
UPLOADUPLOAD-Formular10/31/2013
CORRESPCORRESP-Formular10/22/2013
PRER14CPRER14C-Formular10/22/2013
UPLOADUPLOAD-Formular10/8/2013
PRE 14CPRE 14C-Formular9/20/2013
10-QQuartalsbericht8/14/2013
10-QQuartalsbericht5/17/2013
NT 10-QNT 10-Q-Formular5/15/2013
10-K/A10-K/A-Formular4/23/2013
10-KJahresbericht4/15/2013
NT 10-KNT 10-K-Formular3/29/2013
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben1/30/2013
10-Q/A10-Q/A-Formular11/21/2012
NT 10-QNT 10-Q-Formular11/15/2012
10-QQuartalsbericht11/14/2012
DD-Formular11/13/2012
DD-Formular11/13/2012
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben11/1/2012
10-Q/A10-Q/A-Formular8/21/2012
10-QQuartalsbericht8/14/2012
NT 10-QNT 10-Q-Formular5/15/2012
NT 10-KNT 10-K-Formular3/30/2012
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben1/23/2012
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben1/20/2012
DEF 14CDEF 14C-Formular12/16/2011
UPLOADUPLOAD-Formular12/12/2011
CORRESPCORRESP-Formular12/8/2011
PRER14CPRER14C-Formular12/6/2011
UPLOADUPLOAD-Formular12/1/2011
10-K/A10-K/A-Formular11/21/2011
10-QQuartalsbericht11/14/2011
UPLOADUPLOAD-Formular9/27/2011
10-K/A10-K/A-Formular9/26/2011
10-K/A10-K/A-Formular9/15/2011
UPLOADUPLOAD-Formular8/22/2011
10-QQuartalsbericht8/15/2011
10-K/A10-K/A-Formular8/10/2011
CORRESPCORRESP-Formular8/10/2011
10-K/A10-K/A-Formular8/9/2011
UPLOADUPLOAD-Formular8/9/2011
PRE 14CPRE 14C-Formular8/3/2011
10-Q/A10-Q/A-Formular6/29/2011
UPLOADUPLOAD-Formular6/16/2011
10-QQuartalsbericht5/16/2011
CORRESPCORRESP-Formular5/12/2011
10-K/A10-K/A-Formular5/6/2011
10-Q/A10-Q/A-Formular12/23/2010
10-K/A10-K/A-Formular12/23/2010
CORRESPCORRESP-Formular12/23/2010
RWRW-Formular11/18/2010
10-QQuartalsbericht11/16/2010
NT 10-QNT 10-Q-Formular11/16/2010
RW WDRW WD-Formular11/10/2010
RWRW-Formular11/3/2010
UPLOADUPLOAD-Formular10/29/2010
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben9/20/2010
10-QQuartalsbericht8/23/2010
NT 10-QNT 10-Q-Formular8/16/2010
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben8/3/2010
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben6/11/2008
10-QQuartalsbericht5/20/2008
NT 10-QNT 10-Q-Formular5/16/2008
10KSB10KSB-Formular4/14/2008
NT 10-KNT 10-K-Formular4/1/2008

Positron Documents 2026

This page contains all official documents and SEC filings for Positron stock (POSC, ISIN: US7373976049). This includes annual reports (Form 10-K), quarterly reports (Form 10-Q), and insider transactions (Form 4). Currently 100 documents are available. Data is updated regularly to provide investors with a complete overview of Positron's regulatory filings.

Positron Stock analysis

Positron Positron Corp is a company in the medical technology industry specializing in the development of PET (positron emission tomography) systems and solutions. The company was founded in 1983 as Positron Corporation with headquarters in Houston, Texas, USA. Initially focused on research and development of technologies for radiation therapy, the company shifted its focus to PET imaging and became a pioneer in the field. Positron Corp's business model is based on selling PET systems and related solutions and services to medical facilities and organizations. The company offers both stationary and mobile systems for various applications such as cancer diagnostics. Positron Corp is divided into different divisions specializing in different areas of PET technology, including the development, production, and distribution of PET modules, systems, and software solutions. The flagship product of Positron Corp is the Total-body PET module, which enables complete imaging of the human body and is unique in the medical field. The module was designed to meet the need for whole-body imaging in cancer diagnostics and offers patients a non-invasive way to monitor cancer cells and metastases. In addition to the Total-body PET module, the company also offers specialized solutions for various areas of PET imaging, including a portable PET scanner suitable for use in emergency rooms or intensive care units. Another area of Positron Corp is the development and production of radiation therapy products. The company has developed a range of radiopharmaceuticals that can be used in cancer treatment, including radioisotopes such as fluorine-18, used for labeling molecules in cancer diagnostics, and yttrium-90, used in radiation therapy for the treatment of liver tumors. To ensure that its products remain at the forefront of technology, Positron Corp is heavily involved in research and development. The company collaborates closely with leading research and development companies to develop innovative solutions and technologies that meet the demands of the medical technology industry. Overall, Positron Corp has established itself as a key player in the medical technology industry, developing innovative solutions and technologies for PET imaging and radiation therapy. The company is committed to improving the standard of medical diagnostics and treatment, contributing to the improvement of healthcare.